83 related articles for article (PubMed ID: 6325697)
1. Cell cycle requisite for vesicular stomatitis virus replication in T lymphocytes activated with concanavalin A.
Fujisawa H; Kumazawa Y; Ohtani A; Nishimura C
J Clin Lab Immunol; 1984 Jan; 13(1):41-6. PubMed ID: 6325697
[TBL] [Abstract][Full Text] [Related]
2. Detection of mitogen-activated T and non-T lymphocytes by virus plaque assay. Virus plaque assay on the cells fractionated by unit gravity sedimentation.
Kasahara T; Shioiri-Nakano K; Sugiura A
Immunology; 1977 Jun; 32(6):875-83. PubMed ID: 195900
[TBL] [Abstract][Full Text] [Related]
3. Virus plaque assay: effective detection of virus plaque forming cells at the early stage of lymphocyte activation by mitogen and alloantigen.
Kasahara T; Shioiri-Nakano K; Sugiura A
Immunology; 1979 Mar; 36(3):381-90. PubMed ID: 155653
[TBL] [Abstract][Full Text] [Related]
4. The kinetics of interferon production by mouse lymphocytes and its modulating effect of the virus plaqueforming cell assay as a quantitative method to determine activated lymphocytes.
Heine JW; Adler WH
J Immunol; 1976 Sep; 117(3):1045-8. PubMed ID: 182880
[TBL] [Abstract][Full Text] [Related]
5. Superantigen-activated T cells redirected by a bispecific antibody inhibit vesicular stomatitis virus replication in vitro and in vivo.
Fernandez-Sesma A; Peluso RW; Bai X; Schulman JL; Levy DE; Moran TM
J Immunol; 1998 Feb; 160(4):1841-9. PubMed ID: 9469445
[TBL] [Abstract][Full Text] [Related]
6. Progression of a vesicular stomatitis virus infection in primary lymphocytes is restricted at multiple levels during B cell activation.
Schmidt MR; Gravel KA; Woodland RT
J Immunol; 1995 Sep; 155(5):2533-44. PubMed ID: 7650383
[TBL] [Abstract][Full Text] [Related]
7. Oncolytic activity of vesicular stomatitis virus in primary adult T-cell leukemia.
Césaire R; Olière S; Sharif-Askari E; Loignon M; Lézin A; Olindo S; Panelatti G; Kazanji M; Aloyz R; Panasci L; Bell JC; Hiscott J
Oncogene; 2006 Jan; 25(3):349-58. PubMed ID: 16186807
[TBL] [Abstract][Full Text] [Related]
8. Enumeration of activated thymus-derived lymphocytes by the virus plaque assay.
Kano S; Bloom BR; Howe ML
Proc Natl Acad Sci U S A; 1973 Aug; 70(8):2299-303. PubMed ID: 4365371
[TBL] [Abstract][Full Text] [Related]
9. The production of vesicular stomatitis virus by antigen- or mitogen-stimulated lymphocytes and continuous lymphoblastoid lines.
Nowakowski M; Feldman JD; Kano S; Bloom BR
J Exp Med; 1973 Apr; 137(4):1042-59. PubMed ID: 4348276
[TBL] [Abstract][Full Text] [Related]
10. High frequency detection of different T-cell subsets in mice by a modified virus plaque assay.
Fujisawa H; Kumazawa Y; Ohtani A; Nishimura C
Immunology; 1983 May; 49(1):175-81. PubMed ID: 6601613
[TBL] [Abstract][Full Text] [Related]
11. Virus plaque assay and enumeration of effector cells in mixed lymphocyte cultures.
Bloom BR; Kano S; Howe ML
Transplant Proc; 1973 Dec; 5(4):1705-9. PubMed ID: 4359723
[No Abstract] [Full Text] [Related]
12. T-cell regulation of pokeweed-mitogen-induced polyclonal immunoglobulin production in mice. III. Role of Lyt 1+2- non-helper T cells in the suppression.
Kina T; Nishikawa S; Katsura Y
Immunology; 1982 Nov; 47(3):525-30. PubMed ID: 6290381
[TBL] [Abstract][Full Text] [Related]
13. VSV replication in neurons is inhibited by type I IFN at multiple stages of infection.
Trottier MD; Palian BM; Reiss CS
Virology; 2005 Mar; 333(2):215-25. PubMed ID: 15721356
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses.
Ahmed M; Cramer SD; Lyles DS
Virology; 2004 Dec; 330(1):34-49. PubMed ID: 15527832
[TBL] [Abstract][Full Text] [Related]
15. T cell priming against vesicular stomatitis virus analyzed in situ: red pulp macrophages, but neither marginal metallophilic nor marginal zone macrophages, are required for priming CD4+ and CD8+ T cells.
Ciavarra RP; Buhrer K; Van Rooijen N; Tedeschi B
J Immunol; 1997 Feb; 158(4):1749-55. PubMed ID: 9029112
[TBL] [Abstract][Full Text] [Related]
16. Virus-replicating T cells in the immune response of mice. I. Virus plaque assay of the lymphocytes reactive to sheep erythrocytes.
Minato N; Katsura Y
J Exp Med; 1977 Feb; 145(2):390-404. PubMed ID: 64584
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle progression out of G1 sensitizes primary-cultured nontransformed T cells to TCR-mediated apoptosis.
Radvanyi LG; Shi Y; Mills GB; Miller RG
Cell Immunol; 1996 Jun; 170(2):260-73. PubMed ID: 8660826
[TBL] [Abstract][Full Text] [Related]
18. Priming antiviral cytotoxic T lymphocytes: requirement for CD4+ cells is dependent on the antigen presenting cell in vivo.
Ciavarra RP; Tedeschi B
Cell Immunol; 1994 Aug; 157(1):132-43. PubMed ID: 7913664
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide production by splenic macrophages is not responsible for T cell suppression during acute infection with lactate dehydrogenase-elevating virus.
Rowland RR; Butz EA; Plagemann PG
J Immunol; 1994 Jun; 152(12):5785-95. PubMed ID: 8207208
[TBL] [Abstract][Full Text] [Related]
20. [Effects of Forskolin on proliferation cell-cycle distribution and activation of the murine T lymphocytes in vitro].
Song B; Zeng YY; Huang XY; Li L; Teng F; Yang Z; Yao ML
Zhong Yao Cai; 2008 Jul; 31(7):1008-12. PubMed ID: 18973017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]